Work

The Risk of Hepatocellular Carcinoma in Entecavir Versus Tenofovir Treated US Cohort With Chronic Hepatitis B Virus

Year: 2022

Type: article

Source: Clinical Gastroenterology and Hepatology

DOI: 10.1016/j.cgh.2022.02.056

Authors: Jennifer R. Kramer, Peter A. Richardson, Hyunseok Kim, Yao-Chun Hsu, Fasiha Kanwal, Hashem B. El-Serag

Institutions: Michael E. DeBakey VA Medical Center, Baylor College of Medicine, Fu Jen Catholic University, E-Da Hospital

Language: English

Topic: Hepatitis B Virus Studies

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Gilead Sciences, Center for Innovations in Quality, Effectiveness and Safety, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G230720488, G432500424, G456856876, G5363891937, Texas Medical Center Digestive Diseases Center, Research Training in Gastroenterology

OpenAlex ID: W4221100126

FWCI: 0.902

Cites: 8

Cited by: 5

Related to: 10